Birchview Capital’s Celgene Corp CELG Stock Holding History

Birchview Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-699,648	Closed	-$69.5M	–	58
2019 Q3	$69.5M	Buy	699,648 +1,981	+0.3%	+$188K	46.29%	1
2019 Q2	$64.5M	Sell	697,667 -1,344	-0.2%	-$128K	39.22%	1
2019 Q1	$65.9M	Hold	699,011	–	–	41.32%	1
2018 Q4	$44.8M	Buy	699,011 +28,830	+4%	+$2.13M	42.38%	1
2018 Q3	$60M	Sell	670,181 -16,000	-2%	-$1.41M	38.71%	1
2018 Q2	$54.5M	Sell	686,181 -23,000	-3%	-$1.91M	37.04%	1
2018 Q1	$63.3M	Sell	709,181 -34,870	-5%	-$3.35M	41.66%	1
2017 Q4	$77.6M	Sell	744,051 -17,000	-2%	-$1.92M	45.52%	1
2017 Q3	$111M	Sell	761,051 -14,000	-2%	-$1.91M	57.33%	1
2017 Q2	$101M	Buy	775,051 +8,000	+1%	+$980K	53.25%	1
2017 Q1	$95.4M	Sell	767,051 -10,000	-1%	-$1.2M	53.08%	1
2016 Q4	$89.9M	Hold	777,051	–	–	55.35%	1
2016 Q3	$81.2M	Sell	777,051 -2,000	-0.3%	-$216K	47.4%	1
2016 Q2	$76.8M	Hold	779,051	–	–	55.78%	1
2016 Q1	$78M	Buy	779,051 +2,700	+0.3%	+$278K	55.59%	1
2015 Q4	$93M	Sell	776,351 -20,000	-3%	-$2.31M	53.53%	1
2015 Q3	$86.1M	Buy	796,351 +63,798	+9%	+$7.92M	55.44%	1
2015 Q2	$84.8M	Sell	732,553 -107,610	-13%	-$12.3M	44.79%	1
2015 Q1	$96.9M	Buy	840,163 +26,252	+3%	+$3.14M	50.88%	1
2014 Q4	$91M	Buy	+813,911	New	+$85.8M	52.86%	1

Other funds holding CELG

Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return

HCM

Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return

PCMC

Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return

WCG

Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Birchview Capital's CELG Position: Q4 2019 in Review

Birchview Capital sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 699,648 shares — an estimated $69.5M sold.

Birchview Capital first reported a position in CELG in Q4 2014 and held it in 20 quarters. The position peaked at $111M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

Birchview Capital reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
Birchview Capital sold 699,648 Celgene Corp shares in Q4 2019, an estimated $69.5M.
Birchview Capital first reported a position in Celgene Corp in Q4 2014 and held it in 20 quarters.
Birchview Capital's Celgene Corp position peaked at $111M in Q3 2017.
4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Birchview Capital's 13F filing for Q4 2019, filed 12 Feb 2020.